» Articles » PMID: 36097086

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States

Overview
Journal AIDS Behav
Date 2022 Sep 12
PMID 36097086
Authors
Affiliations
Soon will be listed here.
Abstract

Pre-Exposure Prophylaxis (PrEP) is a priority method for preventing HIV infection. This study's aims were threefold: (1) identify characteristics of members of a large health maintenance organization, Kaiser Permanente Georgia (KPGA), associated with HIV infection, (2) identify which member characteristics associated with HIV were also associated with PrEP prescription, and (3) identify which HIV-associated characteristics were associated with under- or over-prescribing of PrEP. Analysis of variables from the electronic medical record revealed that age, race, gender, mental health diagnosis, STI diagnosis, and sexual orientation were independently associated with HIV diagnosis. The same characteristics were independently associated with PrEP prescription except for race. Persons identifying as Black or unknown race, women, and/or heterosexual; and who had an STI diagnosis and/or illicit drug use had lower odds of being prescribed PrEP than of having an HIV diagnosis. The implications of these findings for improving physician identification of candidates for PrEP prescription are discussed.

References
1.
Smith D, Van Handel M, Grey J . Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018; 28(12):850-857.e9. DOI: 10.1016/j.annepidem.2018.05.003. View

2.
Song H, Squires P, Wilson D, Lo-Ciganic W, Cook R, Park H . Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018. JAMA. 2020; 324(4):395-397. PMC: 7388017. DOI: 10.1001/jama.2020.7312. View

3.
Jones J, deCastro B, August E, Smith D . Pre-exposure Prophylaxis (PrEP) Awareness and Prescribing Behaviors Among Primary Care Providers: DocStyles Survey, 2016-2020, United States. AIDS Behav. 2020; 25(4):1267-1275. DOI: 10.1007/s10461-020-03089-5. View

4.
Marcus J, Volk J, Pinder J, Liu A, Bacon O, Hare C . Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep. 2016; 13(2):116-24. DOI: 10.1007/s11904-016-0308-x. View

5.
Silapaswan A, Krakower D, Mayer K . Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med. 2016; 32(2):192-198. PMC: 5264683. DOI: 10.1007/s11606-016-3899-4. View